Definitive Healthcare Corp. (DH) Stock Price & Analysis
Definitive Healthcare Corp. (DH) closed at USD 1 on Thursday, October 15, 2026, up 1.09% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.99; the Oct 15, 2026 session ranged USD 0.98–1 on volume of 126,131 shares. Market capitalization is $106.33M, with a 52-week range of USD 0.61–3.05 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:19 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DH.md
Key facts (DH)
- Analysts: Hold (mean 3.14 on a 1–5 scale) (7 analysts), mean target USD 1.9 (range 1–3).
- Total return with dividends: 1Y -66.0% vs S&P 500 +18.1%; 5Y -97.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD 0.04, revenue estimate $54.6M.
Analysts (DH)
Consensus Hold (mean 3.14 on a 1–5 scale), 7 analysts; mean target USD 1.9 (low 1, high 3).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | Morgan Stanley | Target lowered | Equal-Weight | $2.5 → $1.5 |
| 2026-06-29 | B of A Securities | Downgrade | Buy → Underperform | $3.5 → $0.7 |
Total return (dividends reinvested) (DH)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -66.0% | -97.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -66.1% | -52.7% |
| Volatility (annualized) | 76.4% | 67.5% |
| Max drawdown | -79.3% (Oct 2025→Jun 2026) | -98.5% (Oct 2021→Aug 2026) |
Key Statistics (as of October 16, 2026 at 05:19 UTC)
| Price | USD 1 |
|---|---|
| Change | ▲ 1.09% (up) |
| Previous Close | USD 0.99 |
| Open | USD 0.98 |
| Day Range | USD 0.98 – 1 |
| 52-Week Range | USD 0.61 – 3.05 |
| Volume | 126,131 shares |
| Market Cap | $106.33M |
| Exchange | NMS |
Technical Analysis (DH)
Nexqual's technical model rates DH "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 16, 2026 at 05:19 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 61.31 (neutral) |
| vs SMA50 | Above (USD 0.88) |
| MACD | 0.02 (positive) |
Analyst Ratings (DH)
Wall Street analysts rate DH "Hold" based on 7 analysts, with a mean price target of USD 1.9 (range USD 1–3), per Nexqual as of October 16, 2026 at 05:19 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 1.9 |
| High Target | USD 3 |
| Low Target | USD 1 |
| Buy / Hold / Sell | 1 / 5 / 1 |
Earnings (DH)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.04 |
| Revenue Estimate | $54.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.05 vs est 0.04 ▲ beat |
| 2026-03-31 | USD 0.06 vs est 0.03 ▲ beat |
| 2025-12-31 | USD 0.06 vs est 0.06 ▼ miss |
| 2025-09-30 | USD 0.07 vs est 0.06 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financials & Fundamentals (DH)
| Total Revenue | $232.70M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -9.10% |
| Gross Margin | +83.76% |
| Operating Margin | -8.55% |
| Profit Margin | -72.28% |
| ROE | -78.37% |
| Debt / Equity | 0.89 |
| Current Ratio | 1.86 |
| Total Cash | $183.80M |
| Total Debt | $167.06M |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financial Health Score (DH)
Nexqual rates Definitive Healthcare Corp.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:19 UTC.
| Growth | Weak — Revenue -4% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 84%, operating -9% |
| Balance Sheet | Mixed — $184M cash vs $167M debt, net cash position |
| Cash Flow | Solid — Operating cash flow $41M (TTM) |
| Efficiency | Critical — ROE -78%, ROA -1.9% |
Ownership (DH)
| Insider Ownership | +3.74% |
|---|---|
| Institutional Ownership | +83.56% |
| Shares Outstanding | 106.74M |
| Float | 38.72M |
| Short % of Float | +3.73% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Leadership (DH)
Definitive Healthcare Corp. is led by Clay Ritchey (age 54), CEO & Director, per Nexqual as of October 16, 2026 at 05:19 UTC.
| CEO & Director | Clay Ritchey (age 54) |
|---|---|
| Founder & Executive Chairman | Jason Ronald Krantz (age 51) |
| Chief Financial Officer | Casey Heller (age 36) |
| Chief Product Officer | Rebecca Marani |
| Senior Vice President of Commercial Center of Excellence | Sally Slarke |
Major Backers & Investors (DH)
Notable institutional backers of Definitive Healthcare Corp. include Goldman Sachs, Shaw D.E. & Co., Inc., Kennedy Capital Management, LLC, according to Nexqual as of October 16, 2026 at 05:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Goldman Sachs | 5.58% |
| Shaw D.E. & Co., Inc. | 1.85% |
| Kennedy Capital Management, LLC | 1.63% |
| Inspire Investing, LLC | 0.84% |
| AQR Capital Management, LLC | 0.84% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio | 0.66% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.4% |
| BlackRock | 1.85% |
| Dimensional Fund Advisors | 1.74% |
| Geode Capital | 0.52% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CARL | Carlsmed, Inc. | USD 13.95 | ▼ 3.59% |
| CTEV | Claritev Corporation | USD 23.86 | ▲ 0.59% |
| NRC | NRC Health | USD 21.11 | ▲ 4.66% |
| EVH | Evolent Health, Inc | USD 4.87 | ▲ 5.87% |
| WEAV | Weave Communications, Inc. | USD 7.39 | ▲ 0.27% |
| SOPH | SOPHiA GENETICS SA | USD 7.29 | ▲ 2.82% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:19 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt